GTC Biotherapeutics (fka GTCB)

[biopearl]

Dew, Eight weeks is a pretty short time frame to pull something with "some style" off. If a further support from an existing partner existed, it would probably have been announced. Agree the revere split seems unlikely. So what is pending in the public domaine that could happen in the next eight weeks? The only thing I see (short of some magic with a generic company like TEVA), is the release of the MM 093 data re RA. This might be a PR spring board for us or an opportunity to highlight a partnership with Merrimack. There is still the Gates foundation, there are visionaries there... Regards, bp